In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

  1. Ocio, E.M.
  2. Vilanova, D.
  3. Atadja, P.
  4. Maiso, P.
  5. Crusoe, E.
  6. Fernández-Lázaro, D.
  7. Garayoa, M.
  8. San-Segundo, L.
  9. Hernández-Iglesias, T.
  10. de Álava, E.
  11. Shao, W.
  12. Yao, Y.-M.
  13. Pandiella, A.
  14. San-Miguel, J.F.
Aldizkaria:
Haematologica

ISSN: 0390-6078,  1592-8721

Argitalpen urtea: 2010

Alea: 95

Zenbakia: 5

Orrialdeak: 794-803

Mota: Artikulua

DOI: 10.3324/HAEMATOL.2009.015495 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus